Principal Financial Group Inc Rocket Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

A detailed history of Principal Financial Group Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 24,702 shares of RCKT stock, worth $456,245. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,702

Previous 30,774 19.73%

Holding current value

$456,245

Previous $829,000 35.95%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$20.66 - $26.72 $125,447 - $162,243	-6,072 Reduced 19.73%	24,702 $531,000
Q1 2024 Apr 29, 2024	BUY	$26.16 - $30.74 $335,135 - $393,810	12,811 Added 71.32%	30,774 $829,000
Q4 2023 Feb 07, 2024	BUY	$16.78 - $31.94 $11,091 - $21,112	661 Added 3.82%	17,963 $538,000
Q3 2023 Nov 02, 2023	SELL	$15.07 - $24.05 $421 - $673	-28 Reduced 0.16%	17,302 $354,000
Q2 2023 Aug 07, 2023	BUY	$16.59 - $23.6 $22,114 - $31,458	1,333 Added 8.33%	17,330 $344,000
Q1 2023 May 09, 2023	BUY	$15.79 - $22.6 $35,811 - $51,256	2,268 Added 16.52%	15,997 $274,000
Q4 2022 Feb 09, 2023	BUY	$15.5 - $22.76 $27,156 - $39,875	1,752 Added 14.63%	13,729 $268,000
Q3 2022 Nov 09, 2022	BUY	$12.37 - $18.41 $148,155 - $220,496	11,977 New	11,977 $191,000
Q4 2021 Feb 09, 2022	SELL	$21.52 - $36.02 $443,613 - $742,516	-20,614 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$27.42 - $48.97 $7,622 - $13,613	278 Added 1.37%	20,614 $616,000
Q2 2021 Aug 10, 2021	BUY	$39.41 - $47.25 $3,822 - $4,583	97 Added 0.48%	20,336 $900,000
Q1 2021 May 10, 2021	BUY	$43.34 - $65.91 $9,144 - $13,907	211 Added 1.05%	20,239 $898,000
Q4 2020 Feb 08, 2021	BUY	$23.3 - $59.57 $214,569 - $548,580	9,209 Added 85.12%	20,028 $1.1 Million
Q3 2020 Nov 06, 2020	BUY	$20.5 - $28.59 $1,168 - $1,629	57 Added 0.53%	10,819 $247,000
Q2 2020 Aug 05, 2020	BUY	$13.32 - $22.61 $143,349 - $243,328	10,762 New	10,762 $225,000

Others Institutions Holding RCKT

# of Institutions

194

Shares Held

91.9M

Call Options Held

222K

Put Options Held

111K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.4B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Rocket Pharmaceuticals, Inc. Transaction History